Howe & Rusling Inc Abbott Laboratories Transaction History

Howe & Rusling Inc

$1.03 Billion
Q1 2024

A detailed history of Howe & Rusling Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Howe & Rusling Inc holds 5,024 shares of ABT stock, worth $510,639. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,024

Previous 4,901 2.51%

Holding current value

$510,639

Previous $539,000 5.94%

% of portfolio

0.06%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $13,470 - $14,878	123 Added 2.51%	5,024 $571,000
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $5,591 - $6,844	62 Added 1.28%	4,901 $539,000
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $10,317 - $12,378	-108 Reduced 2.18%	4,839 $468,000
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $6,248 - $6,961	62 Added 1.27%	4,947 $539,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $2,615 - $3,078	-27 Reduced 0.55%	4,885 $494,000

Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $17,997 - $20,837	186 Added 3.94%	4,912 $475,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $56,444 - $68,223	553 Added 13.25%	4,726 $513,000
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $5,929 - $7,230	-52 Reduced 1.23%	4,173 $494,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $1,964 - $2,404	-17 Reduced 0.4%	4,225 $595,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $2,099 - $2,323	18 Added 0.43%	4,242 $501,000
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $528 - $622	-5 Reduced 0.12%	4,224 $490,000
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $1,959 - $2,308	-18 Reduced 0.42%	4,229 $507,000
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $9,450 - $10,297	90 Added 2.17%	4,247 $465,000
Q3 2020 Nov 06, 2020	SELL	$91.64 - $111.29 $219,936 - $267,096	-2,400 Reduced 36.6%	4,157 $452,000
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $40,964 - $52,430	-535 Reduced 7.54%	6,557 $600,000
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $564,500 - $825,453	-8,986 Reduced 55.89%	7,092 $560,000
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $222,867 - $259,930	-3,058 Reduced 15.98%	16,078 $1.35 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $50,658 - $61,245	-765 Reduced 3.84%	19,136 $1.53 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $4,654 - $5,273	71 Added 0.36%	19,901 $1.44 Million
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $2,979 - $3,594	-49 Reduced 0.25%	19,830 $1.46 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $9,268 - $10,229	-161 Reduced 0.8%	19,879 $1.21 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $301,325 - $340,685	-5,355 Reduced 21.09%	20,040 $1.2 Million
Q4 2017 Jan 24, 2018	BUY	$53.68 - $57.47 $271,137 - $290,280	5,051 Added 24.83%	25,395 $1.45 Million
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $977,732 - $1.09 Million	20,344	20,344 $1.09 Million

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $178B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account